Table 5 End of induction therapy... | American Society of Hematology

Table 5

End of induction therapy response rates

Patients	G-CHOP						G-FC
	400/400 mg (n = 14)		1600/800 mg (n = 14)		Total (n = 28)		400/400 mg (n = 14)		1600/800 mg (n = 14)		Total (n = 28)
	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
ORR	13	93	14	100	27	96	14	100	12	86	26	93
CR	2	14	9	64	11	39	11	79	3	21	14	50
PR	11	79	5	36	16	57	3	21	9	64	12	43
SD	1	7	0	0	1	4	0	0	0	0	0	0
PD	0		0	0	0	0	0	0	1	7	1	4

Patients	G-CHOP						G-FC
	400/400 mg (n = 14)		1600/800 mg (n = 14)		Total (n = 28)		400/400 mg (n = 14)		1600/800 mg (n = 14)		Total (n = 28)
	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
ORR	13	93	14	100	27	96	14	100	12	86	26	93
CR	2	14	9	64	11	39	11	79	3	21	14	50
PR	11	79	5	36	16	57	3	21	9	64	12	43
SD	1	7	0	0	1	4	0	0	0	0	0	0
PD	0		0	0	0	0	0	0	1	7	1	4

ORR, overall response rate; progressive disease; SD, stable disease.